Arrowhead Pharmaceuticals Corp (ARWR)

18.02 -0.08 (0.44%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (5/8/19 *Est.)

Latest Headlines

Form 4 ARROWHEAD PHARMACEUTICAL For: Feb 19 Filed by: Myszkowski Kenneth Allen February 20, 2019 8:14 PM - SEC Filing Form 4 ARROWHEAD PHARMACEUTICAL For: Feb 15 Filed by: GIVEN BRUCE D February 20, 2019 8:11 PM - SEC Filing Form SC 13G/A ARROWHEAD PHARMACEUTICAL Filed by: RTW INVESTMENTS, LP February 14, 2019 9:23 AM - SEC Filing Form SC 13G ARROWHEAD PHARMACEUTICAL Filed by: STATE STREET CORP February 13, 2019 3:30 PM - SEC Filing Form 4 ARROWHEAD PHARMACEUTICAL For: Feb 08 Filed by: GIVEN BRUCE D February 12, 2019 9:00 PM - SEC Filing Form SC 13G ARROWHEAD PHARMACEUTICAL Filed by: FIRST MANHATTAN CO February 11, 2019 11:04 AM - SEC Filing Form SC 13G ARROWHEAD PHARMACEUTICAL Filed by: BlackRock Inc. February 8, 2019 6:12 AM - SEC Filing Form 4 ARROWHEAD PHARMACEUTICAL For: Feb 05 Filed by: GIVEN BRUCE D February 7, 2019 8:37 PM - SEC Filing Form 10-Q ARROWHEAD PHARMACEUTICAL For: Dec 31 February 7, 2019 4:53 PM - SEC Filing Form 8-K ARROWHEAD PHARMACEUTICAL For: Feb 07 February 7, 2019 4:27 PM - SEC Filing Arrowhead Pharmaceuticals Corp (ARWR) Misses Q1 EPS by 41c, Revenues Miss February 7, 2019 4:02 PM - StreetInsider Arrowhead Pharmaceuticals Reports Fiscal 2019 First Quarter Results February 7, 2019 4:00 PM - BizWire Form 4 ARROWHEAD PHARMACEUTICAL For: Feb 01 Filed by: GIVEN BRUCE D February 1, 2019 7:53 PM - SEC Filing Form 8-K ARROWHEAD PHARMACEUTICAL For: Jan 28 January 29, 2019 5:02 PM - SEC Filing Form DEFA14A ARROWHEAD PHARMACEUTICAL January 25, 2019 4:18 PM - SEC Filing Form DEF 14A ARROWHEAD PHARMACEUTICAL For: Mar 14 January 25, 2019 4:12 PM - SEC Filing Form 4 ARROWHEAD PHARMACEUTICAL For: Jan 22 Filed by: GIVEN BRUCE D January 24, 2019 8:54 PM - SEC Filing Form 4 ARROWHEAD PHARMACEUTICAL For: Jan 22 Filed by: GIVEN DOUGLAS B January 24, 2019 8:47 PM - SEC Filing Arrowhead Pharmaceuticals to Webcast Fiscal 2019 First Quarter Results January 24, 2019 4:00 PM - BizWire Form 4 ARROWHEAD PHARMACEUTICAL For: Jan 18 Filed by: O'Brien Patrick January 18, 2019 7:02 PM - SEC Filing Form 4 ARROWHEAD PHARMACEUTICAL For: Jan 17 Filed by: Myszkowski Kenneth Allen January 18, 2019 7:01 PM - SEC Filing Form 4 ARROWHEAD PHARMACEUTICAL For: Jan 14 Filed by: Li Zhen January 16, 2019 8:25 PM - SEC Filing Form 4 ARROWHEAD PHARMACEUTICAL For: Jan 14 Filed by: GIVEN BRUCE D January 16, 2019 8:20 PM - SEC Filing Form SC 13G/A ARROWHEAD PHARMACEUTICAL Filed by: OppenheimerFunds, Inc. January 14, 2019 3:13 PM - SEC Filing Form 4 ARROWHEAD PHARMACEUTICAL For: Jan 11 Filed by: Waddill William D. January 11, 2019 6:16 PM - SEC Filing Form 8-K ARROWHEAD PHARMACEUTICAL For: Jan 07 January 11, 2019 5:13 PM - SEC Filing Arrowhead Pharmaceuticals Corp (ARWR) Reports Filing of Regulatory Clearance to Begin Phase 1 Study of ARO-APOC3 for Treatment of Hypertriglyceridemia January 7, 2019 7:40 AM - StreetInsider Arrowhead Pharmaceuticals Corp (ARWR) Reports First Patient Dosing in Phase 1 Study of ARO-ANG3 for Treatment of Dyslipidemias and Metabolic Diseases January 7, 2019 7:31 AM - StreetInsider Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1 Study of ARO-APOC3 for Treatment of Hypertriglyceridemia January 7, 2019 7:30 AM - BizWire Arrowhead Pharmaceuticals Begins Dosing in Phase 1 Study of ARO-ANG3 for Treatment of Dyslipidemias and Metabolic Diseases January 7, 2019 7:30 AM - BizWire Form 4 ARROWHEAD PHARMACEUTICAL For: Jan 01 Filed by: Waddill William D. January 3, 2019 8:20 PM - SEC Filing Form 4 ARROWHEAD PHARMACEUTICAL For: Jan 02 Filed by: Ferrari Mauro January 3, 2019 8:18 PM - SEC Filing Form 4 ARROWHEAD PHARMACEUTICAL For: Jan 01 Filed by: PERRY MICHAEL S January 3, 2019 8:17 PM - SEC Filing Form 4 ARROWHEAD PHARMACEUTICAL For: Jan 01 Filed by: GIVEN DOUGLAS B January 3, 2019 8:15 PM - SEC Filing Form 4 ARROWHEAD PHARMACEUTICAL For: Jan 01 Filed by: Li Zhen January 3, 2019 8:09 PM - SEC Filing Form 4 ARROWHEAD PHARMACEUTICAL For: Jan 01 Filed by: O'Brien Patrick January 3, 2019 7:59 PM - SEC Filing Form 4 ARROWHEAD PHARMACEUTICAL For: Jan 01 Filed by: Myszkowski Kenneth Allen January 3, 2019 7:56 PM - SEC Filing Form 4 ARROWHEAD PHARMACEUTICAL For: Jan 01 Filed by: GIVEN BRUCE D January 3, 2019 7:55 PM - SEC Filing Form 4 ARROWHEAD PHARMACEUTICAL For: Jan 01 Filed by: Anzalone Christopher Richard January 3, 2019 7:50 PM - SEC Filing Form 4 ARROWHEAD PHARMACEUTICAL For: Dec 27 Filed by: GIVEN DOUGLAS B December 28, 2018 5:22 PM - SEC Filing Form 4 ARROWHEAD PHARMACEUTICAL For: Dec 19 Filed by: Anzalone Christopher Richard December 21, 2018 5:16 PM - SEC Filing Form 4 ARROWHEAD PHARMACEUTICAL For: Dec 18 Filed by: Ferrari Mauro December 19, 2018 7:41 PM - SEC Filing Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) December 17, 2018 6:06 PM - BizWire Form 4 ARROWHEAD PHARMACEUTICAL For: Dec 12 Filed by: Anzalone Christopher Richard December 14, 2018 5:19 PM - SEC Filing Form 10-K ARROWHEAD PHARMACEUTICAL For: Sep 30 December 11, 2018 4:14 PM - SEC Filing Form 8-K ARROWHEAD PHARMACEUTICAL For: Dec 11 December 11, 2018 4:06 PM - SEC Filing Arrowhead Pharmaceuticals Reports Fiscal 2018 Year End Results December 11, 2018 4:00 PM - BizWire Form S-3ASR ARROWHEAD PHARMACEUTICAL November 29, 2018 5:22 PM - SEC Filing Arrowhead Pharmaceuticals to Webcast 2018 Fiscal Year End Results November 27, 2018 7:30 AM - BizWire Form 4 ARROWHEAD PHARMACEUTICAL For: Nov 23 Filed by: GIVEN DOUGLAS B November 26, 2018 9:12 PM - SEC Filing Full Article List